These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 7563864
21. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. Chiesa R, Donato F, Tagger A, Favret M, Ribero ML, Nardi G, Gelatti U, Bucella E, Tomasi E, Portolani N, Bonetti M, Bettini L, Pelizzari G, Salmi A, Savio A, Garatti M, Callea F. Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484 [Abstract] [Full Text] [Related]
22. [Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm]. Tarao K, Shimizu A, Okawa S, Tamai S. Nihon Naika Gakkai Zasshi; 1995 Dec 10; 84(12):1985-91. PubMed ID: 8586918 [No Abstract] [Full Text] [Related]
23. [Hepatitis C in France]. Dhumeaux D. Gastroenterol Clin Biol; 2002 Apr 10; 26 Spec No 2():B133-7. PubMed ID: 12180280 [No Abstract] [Full Text] [Related]
24. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing. Fattovich G, Llovet JM. J Hepatol; 2006 Jun 10; 44(6):1013-6. PubMed ID: 16678654 [No Abstract] [Full Text] [Related]
25. Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis. Macaron C, Hanouneh IA, Zein NN. Hepatology; 2010 Dec 10; 52(6):2239; author reply 2239-40. PubMed ID: 21105115 [No Abstract] [Full Text] [Related]
26. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis. Tarao K, Fujiyama S, Ohkawa S, Miyakawa K, Tamai S, Hirokawa S, Masaki T, Tanaka K. Cancer Epidemiol Biomarkers Prev; 2005 Jan 10; 14(1):164-9. PubMed ID: 15668491 [Abstract] [Full Text] [Related]
27. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Macías Rodríguez MA, Rendón Unceta P, Tejada Cabrera M, Infante Hernández JM, Correro Aguilar F, Díaz García F, Benítez Rodríguez E, Mangas Rojas A, Martín Herrera L. Rev Esp Enferm Dig; 2000 Jul 10; 92(7):458-69. PubMed ID: 11026763 [Abstract] [Full Text] [Related]
29. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis. Di Costanzo GG, De Luca M, Tritto G, Lampasi F, Addario L, Lanza AG, Tartaglione MT, Picciotto FP, Ascione A. Eur J Gastroenterol Hepatol; 2008 Jul 10; 20(7):674-9. PubMed ID: 18679071 [Abstract] [Full Text] [Related]
30. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP). Am J Gastroenterol; 2002 Nov 10; 97(11):2886-95. PubMed ID: 12425564 [Abstract] [Full Text] [Related]
31. [Hepatitis-C virus and hepatoma]. Zala G, Havelka J, Altorfer J, Joller-Jemelka HJ, Risti B, Meier B, Schmid M, Bühler H. Schweiz Med Wochenschr; 1992 Feb 08; 122(6):194-7. PubMed ID: 1311125 [Abstract] [Full Text] [Related]
32. [Natural course and progression of liver cirhosis in patients with hepatitis C]. Franke A, Zeuzem S. Z Gastroenterol; 1998 Jun 08; 36(6):539-41. PubMed ID: 9675840 [No Abstract] [Full Text] [Related]
33. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study. Vaiphei K, Pal NS, Arora SK. Indian J Pathol Microbiol; 2006 Jul 08; 49(3):357-61. PubMed ID: 17001884 [Abstract] [Full Text] [Related]
35. [Assessment of survival and risk of hepatocellular carcinoma in patients with cirrhosis of mixed (viral, alcoholic) etiology]. Lopatkina TN, Tanashchuk EL, Siutkin VE, Popova IV. Ter Arkh; 2002 Jul 08; 74(2):44-6. PubMed ID: 11899824 [Abstract] [Full Text] [Related]